SKU: TIR30
$229.99
0 Reviews
Product Overview:
Tirzepatide is a novel, once-weekly subcutaneous injectable medication designed to support glycemic control and weight management in individuals with type 2 diabetes and/or obesity. As a dual incretin agonist, Tirzepatide activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, offering a synergistic mechanism that enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety.
Key Features:
- Dual Receptor Activation: Targets both GLP-1 and GIP pathways for enhanced glucose regulation and weight reduction.
- Improved Glycemic Control: Demonstrated significant A1C reduction in clinical trials.
- Weight Loss Support: Clinically proven to reduce body weight in individuals with obesity or overweight, with or without diabetes.
- Convenient Dosing: Once-weekly subcutaneous injection for improved adherence and patient convenience.
- Cardiometabolic Benefits: Potential improvements in cardiovascular risk factors, pending further study.
Description
Other Features:
- High Purity: ≥99%
- Form: Lyophilized powder
- Concentration: 30mg per vial
- Storage: Store in a freezer in powder form. Once reconstituted, store in a refrigerator.
- Solubility: Readily soluble in sterile water or research buffers
- Why Choose Our Tirzepatide 30mg:
- Reliable, lab-grade quality
- Fast shipping and secure packaging
Intended Use:
This product is for research use only. It is not intended for human or veterinary consumption. Ideal for use in controlled laboratory experiments exploring peptide therapeutics, metabolic research, and preclinical studies.
Disclaimer:
Buyer assumes all responsibility for the safe handling and use of this material. This compound should only be handled by qualified professionals in a controlled laboratory setting.
related products
-
Quick View -
Quick View -
Quick View -
Quick View